Literature DB >> 23499461

Embryonic stem cell-based modeling of tau pathology in human neurons.

Jerome Mertens1, Kathrin Stüber, Daniel Poppe, Jonas Doerr, Julia Ladewig, Oliver Brüstle, Philipp Koch.   

Abstract

Alterations in the microtubule (MT)-associated protein, tau, have emerged as a pivotal phenomenon in several neurodegenerative disorders, including frontotemporal dementia and Alzheimer's disease. Although compelling lines of evidence from various experimental models suggest that hyperphosphorylation and conformational changes of tau can cause its aggregation into filaments, the actual tau species and effective mechanisms that conspire to trigger the degeneration of human neurons remain obscure. Herein, we explored whether human embryonic stem cell-derived neural stem cells can be exploited to study consequences of an overexpression of 2N4R tau (two normal N-terminal and four MT-binding domains; n-tau) versus pseudohyperphosphorylated tau (p-tau) directly in human neurons. Given the involvement of tau in MT integrity and cellular homeostasis, we focused on the effects of both tau variants on subcellular transport and neuronal survival. By using inducible lentiviral overexpression, we show that p-tau, but not n-tau, readily leads to an MC-1-positive protein conformation and impaired mitochondrial transport. Although these alterations do not induce cell death under standard culture conditions, p-tau-expressing neurons cultured under non-redox-protected conditions undergo degeneration with formation of axonal varicosities sequestering transported proteins and progressive neuronal cell death. Our data support a causative link between the phosphorylation and conformational state of tau, microtubuli-based transport, and the vulnerability of human neurons to oxidative stress. They further depict human embryonic stem cell-derived neurons as a useful experimental model for studying tau-associated cellular alterations in an authentic human system.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499461     DOI: 10.1016/j.ajpath.2013.01.043

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.

Authors:  Patrick Reilly; Charisse N Winston; Kelsey R Baron; Margarita Trejo; Edward M Rockenstein; Johnny C Akers; Najla Kfoury; Marc Diamond; Eliezer Masliah; Robert A Rissman; Shauna H Yuan
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

2.  Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.

Authors:  Jonas Doerr; Annika Böckenhoff; Benjamin Ewald; Julia Ladewig; Matthias Eckhardt; Volkmar Gieselmann; Ulrich Matzner; Oliver Brüstle; Philipp Koch
Journal:  Mol Ther       Date:  2015-06-10       Impact factor: 11.454

Review 3.  Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Qian Cai; Prasad Tammineni
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration.

Authors:  Xiu-Tang Cheng; Ning Huang; Zu-Hang Sheng
Journal:  Neuron       Date:  2022-04-16       Impact factor: 18.688

5.  Druggable transcriptomic pathways revealed in Parkinson's patient-derived midbrain neurons.

Authors:  Mark van den Hurk; Shong Lau; Maria C Marchetto; Jerome Mertens; Shani Stern; Olga Corti; Alexis Brice; Beate Winner; Jürgen Winkler; Fred H Gage; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2022-10-18

6.  Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects.

Authors:  Jerome Mertens; Apuã C M Paquola; Manching Ku; Emily Hatch; Lena Böhnke; Shauheen Ladjevardi; Sean McGrath; Benjamin Campbell; Hyungjun Lee; Joseph R Herdy; J Tiago Gonçalves; Tomohisa Toda; Yongsung Kim; Jürgen Winkler; Jun Yao; Martin W Hetzer; Fred H Gage
Journal:  Cell Stem Cell       Date:  2015-10-08       Impact factor: 24.633

7.  Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.

Authors:  Teresa Sposito; Elisavet Preza; Colin J Mahoney; Núria Setó-Salvia; Natalie S Ryan; Huw R Morris; Charles Arber; Michael J Devine; Henry Houlden; Thomas T Warner; Trevor J Bushell; Michele Zagnoni; Tilo Kunath; Frederick J Livesey; Nick C Fox; Martin N Rossor; John Hardy; Selina Wray
Journal:  Hum Mol Genet       Date:  2015-07-01       Impact factor: 6.150

Review 8.  Neurodegenerative Implications of Neuronal Cytoplasmic Protein Dysfunction in Response to Environmental Contaminants.

Authors:  Odia Osemwegie; Seshadri Ramkumar; Ernest E Smith
Journal:  Neurotox Res       Date:  2020-11-11       Impact factor: 3.911

9.  Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS.

Authors:  Ana Jovičić; Jerome Mertens; Steven Boeynaems; Elke Bogaert; Noori Chai; Shizuka B Yamada; Joseph W Paul; Shuying Sun; Joseph R Herdy; Gregor Bieri; Nicholas J Kramer; Fred H Gage; Ludo Van Den Bosch; Wim Robberecht; Aaron D Gitler
Journal:  Nat Neurosci       Date:  2015-09       Impact factor: 24.884

10.  APP processing in human pluripotent stem cell-derived neurons is resistant to NSAID-based γ-secretase modulation.

Authors:  Jerome Mertens; Kathrin Stüber; Patrick Wunderlich; Julia Ladewig; Jaideep C Kesavan; Rik Vandenberghe; Mathieu Vandenbulcke; Philip van Damme; Jochen Walter; Oliver Brüstle; Philipp Koch
Journal:  Stem Cell Reports       Date:  2013-12-05       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.